Medication for svt
Pro Research Analysisby 
Searched over 200M research papers
Medications for Supraventricular Tachycardia (SVT)
Introduction to SVT and Its Management
Supraventricular tachycardia (SVT) is a common cardiac arrhythmia that originates above the ventricles. It often requires emergent care, especially in infants and children. Various medications are used to manage and prevent SVT, each with its own efficacy and safety profile.
Digoxin vs. Propranolol in Infants
A multicenter, randomized controlled trial compared the efficacy and safety of digoxin and propranolol in infants under four months with SVT. The study found no significant difference in SVT recurrence between the two medications. SVT recurred in 19% of patients on digoxin and 31% on propranolol, with no serious adverse events reported for either drug .
Ivabradine for Refractory SVT in Children
Ivabradine, typically used for coronary artery disease and heart failure, has shown promise in treating refractory SVT in pediatric patients. A retrospective study indicated that ivabradine successfully reverted SVT to sinus rhythm in two out of three children with treatment-resistant SVT, suggesting it as a potential option for difficult cases .
Propranolol vs. Diltiazem Post-Coronary Artery Bypass Grafting
In adults undergoing coronary artery bypass grafting, propranolol was found to be more effective than diltiazem in preventing postoperative SVT. Propranolol significantly reduced the incidence of SVT to 7%, compared to 35% in the diltiazem and control groups .
Etripamil Nasal Spray for Paroxysmal SVT
Etripamil, a short-acting calcium-channel blocker administered via nasal spray, is under investigation for the rapid termination of paroxysmal SVT. Early phase clinical trials have shown it to be a convenient, safe, and effective option, potentially improving quality of life and reducing healthcare utilization for patients with paroxysmal SVT .
Combination Therapy in Neonates
A study on neonatal SVT management highlighted the need for combination pharmacologic therapy. While propranolol and amiodarone were the most commonly used medications, 61% of neonates required two or more drugs to control SVT effectively. This underscores the importance of tailored treatment plans for neonates .
Safety and Efficacy of Medical Therapy in Infants
A review of 112 infants treated for SVT showed that digoxin and propranolol were effective in 70% of cases. Class I and III antiarrhythmic agents were necessary for some patients, and radiofrequency ablation was reserved for those who failed medical management. No deaths were attributed to antiarrhythmic medications, indicating their safety in this population .
Conclusion
The management of SVT involves a variety of medications, each with specific indications and efficacy profiles. Digoxin and propranolol are commonly used in infants, while ivabradine shows promise for refractory cases. Propranolol is effective post-surgery, and etripamil nasal spray offers a novel approach for paroxysmal SVT. Combination therapy is often necessary in neonates, and overall, medical therapy remains a safe and effective option for managing SVT in infants and children.
Sources and full results
Most relevant research papers on this topic
Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting.
Low-dose propranolol is a safe and effective drug prophylaxis to avoid supraventricular tachyarrhythmias after coronary bypass surgery.
DOI